跳至主要内容
临床试验/KCT0000972
KCT0000972终止未知

A Multicenter, Randomized, Active-controlled, Parallel, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Asthmon?(Montelukast) in Children with Symptom Control due to Persistent Allergic Rhinitis

Dong Hwa Pharm0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
6(Year) 至 14(Year)(—)
性别
All

入选标准

  • 1. Persistent Nasal symptom for more than 4 days and 4 weeks per week or more , and the duration and specificity of immunoglobulin-positive test results identified children with persistent allergic rhinitis
  • 2. Randomized at baseline TNSS score of the previous three days more than the average of 3 points
  • 3. Subjects and subjects representative(guardian) to participate in this clinical trial voluntarily provided written informed consent, and if consent

排除标准

  • 1. Within 2 weeks before screening Otolaryngology ever experienced patients infected
  • 2. Steroid therapy, and patients with asthma who need
  • 3. During clinical trials, systemic steroids or antihistamines necessary medical treatment and patients with the skin disease

研究者

发起方
Dong Hwa Pharm

相似试验